Lysosomal-associated membrane protein 3 (LAMP3) (LAMP3)

Lysosomal-associated membrane protein 3 (LAMP3), also known as CD208 or DC-LAMP, is a type I transmembrane glycoprotein primarily localized to the lysosomal membranes of mature dendritic cells (UniProt P55087). It plays a pivotal role in the maturation of dendritic cells and the subsequent activation of T-cells during the adaptive immune response (PubMed: 11069074). Beyond its physiological role, LAMP3 mRNA is frequently overexpressed in various malignancies, including cervical, esophageal, and breast cancers, where it is associated with hypoxia-induced unfolded protein response (UPR) and promotes tumor cell migration and metastasis (PubMed: 25605115). In the context of therapeutic development, LAMP3 mRNA is targeted by experimental RNA interference (RNAi) strategies, such as small interfering RNAs (siRNAs), to suppress its expression and inhibit oncogenic progression. Additionally, LAMP3-encoding mRNA is utilized in the development of dendritic cell-based vaccines aimed at enhancing anti-tumor immunity. Clinical interest also extends to its role as a biomarker for Sjogren's syndrome and as a prognostic indicator in solid tumors. Safety considerations for targeting LAMP3 mRNA include potential off-target silencing and the induction of unintended inflammatory responses by RNA-based delivery systems.

Other names

CD208DC-LAMPTSC403Lysosomal-associated membrane glycoprotein 3

RNA interference (siRNA-mediated degradation of mRNA) or mRNA-based expression for dendritic cell-mediated immunotherapy.